InvestorsHub Logo

Monroe1

06/21/20 6:33 PM

#86002 RE: Venture_Cap #85981


From back in February. I would expect COVID has taken a cattle prod to production. July is going to make history for longs.


Preparations Underway For Commercial Scale-Up

Currently, CytoDyn is producing 2,000 liters per run, with immediate capacity to produce 12,000 liters per run. Upon approvals of leronlimab for its various indications, Pourhassan plans to leverage Samsung Biologics’ 180,000 liter-per-run capacity and Lonza’s 150,000 liter capacity to facilitate the product’s commercial scale-up. And while it’s currently filled to vials, he says the company is already planning the switch to prefilled syringes of leronlimab to meet commercial demand. “The transition to prefilled syringes is strategic for both patient centricity and supply chain efficiency,” explains Pourhassan. “The patient will simply remove the syringe from its box, self-inject, and dispose of the syringe per the instructions on the box. This will eliminate the waste of a significant amount of material.”

ombowstring

06/21/20 7:22 PM

#86015 RE: Venture_Cap #85981

I'd like to see them stop the Phase 2b/3 for efficacy and give everyone in the trial leronlimab.